Filter

51 - 60 of 255 Results

  • Analysis: There is Significant Variation in State and Local Eligibility Criteria for Monkeypox Vaccines, and Vaccine Information is not Always Accessible

    News Release

    According to a new KFF analysis assessing monkeypox (MPX) vaccine eligibility across the United States, people who are exposed or presumed exposed to MPX are generally eligible to get a vaccine across the country. However, eligibility varies across the United States for certain workers, including laboratory staff and others who might be at increased risk.

  • Assessing Monkeypox (MPX) Vaccine Eligibility Across the United States

    Issue Brief

    This analysis examines jurisdictional approaches to eligibility for monkeypox (MPX) vaccine. Overall, almost all jurisdictions have, at minimum, adopted the current approach laid out by the CDC. However, there is substantial variation in how eligibility is defined. Additionally, several jurisdictions lack clear criteria or information on who is eligible or where to get vaccinated. This may impact on who gets vaccinated, lead to geographic disparities, and raises potentially equity challenges.

  • Monkeypox (MPX) Cases and Vaccinations by Race/Ethnicity

    Issue Brief

    A small number of states, as well as some local jurisdictions, are reporting race/ethnicity data on MPX cases and vaccinations and these data show a disproportionate impact of MPX cases on Black and Hispanic people. The data available to date on vaccinations also suggest that Black and Hispanic people are receiving smaller shares of vaccinations despite accounting for larger shares of cases.

  • COVID-19 Vaccination Rates Among Children Under 5 Have Peaked and Are Decreasing Just Weeks Into Their Eligibility

    Issue Brief

    Children between the ages of 6 months and 5 years of age finally became eligible for COVID-19 vaccination in the U.S. on June 18, after the Director of the Centers for Disease Control and Prevention (CDC) recommended their use for this population, following emergency use authorization granted by the Food and Drug Administration. Here, we examine the status of vaccine uptake in this group, one month into their eligibility.

  • Do States with Easier Access to Guns have More Suicide Deaths by Firearm?

    Issue Brief

    The recent mass shootings in Uvalde and Buffalo have catalyzed discussion around mental health and gun policy. In the same week that the federal Bipartisan Safer Communities Act was signed strengthening background checks for young adults, adding incentives for red flag laws, and reducing access to guns for individuals with a domestic violence history, the Supreme Court struck down New York’s “proper cause” requirement for concealed carry allowances. In this issue brief, we use the Center for Disease Control and Prevention (CDC) Wonder database and the State Firearm Law Database to examine the association between suicide deaths by firearm and the number of state-level firearm law provisions.

  • Reading the Post-Roe Tea Leaves in States Without Abortion Bans or Protections

    Policy Watch

    In the 17 states without explicit laws prohibiting or protecting abortions, we present a number of indicators to assess abortion access, including abortion restrictions, the number of clinics and women of reproductive age per clinic, as well as State Supreme Court rulings interpreting the right to abortion in that state.

  • Help with Medicare Premium and Cost-Sharing Assistance Varies by State

    Issue Brief

    This data note provides an overview of programs that help beneficiaries with modest incomes with their Medicare costs, including the Medicare Savings Programs and the Part D Low-Income Subsidy, and highlights findings from corresponding state-level profiles of eligibility and enrollment.

  • Medicare State Profiles

    Interactive

    These state profiles capture the variations across states in the number and characteristics of Medicare beneficiaries through the Medicare Savings Programs and Medicare’s Part D Low-Income Subsidy.